SCHEMBL728283

SCHEMBL728283

Cc1cccc(N(c2ccc(N(c3cccc(C)c3)c3cccc(C)c3)cc2)c2cccc(C)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.52
TDP1 Q9NUW8 4/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
NSD2 O96028 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
ALDH1A1 P00352 5/20 0.42
MAPK1 P28482 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4518120 1.00 ACHE (0.52) ACHETDP1NPC1RAB9AMEN1
SCHEMBL3441917 0.95 ACHE (0.48) ACHETDP1NPC1RAB9AMEN1
SCHEMBL13017732 0.95 ALDH1A1 (0.48) ACHETDP1NPC1RAB9AMEN1
SCHEMBL26563 0.95 ALDH1A1 (0.48) ACHETDP1NPC1RAB9AMEN1
SCHEMBL13720602 0.95 ALDH1A1 (0.48) ACHETDP1NPC1RAB9AMEN1
SCHEMBL19075300 0.95 ACHE (0.48) ACHETDP1NPC1RAB9AMEN1
SCHEMBL13844494 0.95 ALDH1A1 (0.48) ACHETDP1NPC1RAB9AMEN1
SCHEMBL10065627 0.95 ALDH1A1 (0.48) ACHETDP1NPC1RAB9AMEN1
SCHEMBL22812841 0.95 ALDH1A1 (0.48) ACHETDP1NPC1RAB9AMEN1
SCHEMBL10065551 0.95 ALDH1A1 (0.48) ACHETDP1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11539005-B2 Transition metal complexes comprising carbene ligands serving as emitters for organic light-emitting diodes (OLED's) UDC IRELAND LIMITED (IE) 2022-12-27 US disclosed
US-20200266366-A1 TRANSITION METAL COMPLEXES COMPRISING CARBENE LIGANDS SERVING AS EMITTERS FOR ORGANIC LIGHT-EMITTING DIODES (OLED'S) UDC IRELAND LTD (IE) 2020-08-20 US disclosed
US-10573828-B2 Transition metal complexes comprising carbene ligands serving as emitters for organic light-emitting diodes (OLED's) UDC IRELAND LIMITED (IE) 2020-02-25 US disclosed
US-20170365802-A1 TRANSITION METAL COMPLEXES COMPRISING CARBENE LIGANDS SERVING AS EMITTERS FOR ORGANIC LIGHT-EMITTING DIODES (OLED'S) UDC IRELAND LTD (IE) 2017-12-21 US disclosed
US-9748498-B2 Transition metal complexes comprising carbene ligands serving as emitters for organic light-emitting diodes (OLED's) UDC IRELAND LIMITED (IE) 2017-08-29 US disclosed
US-9024308-B2 Transition metal complexes with carbene ligands as emitters for organic light-emitting diodes (OLEDs) BASF SE (DE) 2015-05-05 US disclosed
US-20150073152-A1 TRANSITION METAL COMPLEXES WITH CARBENE LIGANDS AS EMITTERS FOR ORGANIC LIGHT-EMITTING DIODES (OLEDS) BASF SE (DE) 2015-03-12 US disclosed
US-8916853-B2 Transition metal complexes comprising carbene ligands serving as emitters for organic light-emitting diodes (OLED's) BASF SE (DE) 2014-12-23 US disclosed
US-8586197-B2 Composite material, light emitting element, light emitting device and electronic appliance using the composite material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-11-19 US disclosed
US-8586197-B2 Composite material, light emitting element, light emitting device and electronic appliance using the composite material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-11-19 US disclosed
US-20110049501-A1 TRANSITION METAL COMPLEXES COMPRISING CARBENE LIGANDS SERVING AS EMITTERS FOR ORGANIC LIGHT-EMITTING DIODES (OLED'S) BASF AKTIENGESELLSCHAFT (DE) 2011-03-03 US disclosed
US-7846763-B2 starting from N,N-diphenylethane-1,2-diamine; bisamine is reacted with triethyl formate in the presence of ammonium tetrafluoroborate; suitable for producing electroluminescence in the blue, red and green regions of the electromagnetic spectrum BASF AKTIENGESELLSCHAFT (DE) 2010-12-07 US disclosed
US-7790888-B2 Method for producing tris-ortho-metallated complexes and use of such complexes in OLEDs BASF AKTIENGESELLSCHAFT (DE) 2010-09-07 US disclosed
US-20100221040-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR AND APPARATUS FOR IMAGE FORMATION MITSUBISHI CHEMICAL CORPORATION 2010-09-02 US disclosed
US-20080213623-A1 7,10-bis(acryloyl, styryl, or glycidyl-substituted phenyl)fluoranthene polymerized in the presence of a nickel or palladium catalyst; photopolymerized after applied to film substrate for organic light-emitting diodes; improved stability, high efficiency and quantum yield, emission maximum in blue region BASF AKTIENGESELLSCHAFT (DE) 2008-09-04 US disclosed
US-20080136325-A1 Composite Material, Light Emitting Element, Light Emitting Device and Electronic Appliance Using the Composite Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-06-12 US disclosed
US-20080136325-A1 Composite Material, Light Emitting Element, Light Emitting Device and Electronic Appliance Using the Composite Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-06-12 US disclosed
US-20070287821-A1 Synthesis of Polynaphthalenes and Their Use BASF AKTIENGESELLSCHAFT (DE) 2007-12-13 US disclosed
US-20070080342-A1 Method for producing tris-ortho-metallated complexes and use of such complexes in oleds BASF AKTIENGESELLSCHAFT (DE) 2007-04-12 US disclosed
US-20060258043-A1 Transition metal complexes comprising carbene ligands serving as emitters for organic light-emitting diodes (oled's) BASF AKTIENGESELLSCHAFT (DE) 2006-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170365802-A1 TRANSITION METAL COMPLEXES COMPRISING CARBENE LIGANDS SERVING AS EMITTERS FOR ORGANIC LIGHT-EMITTING DIODES (OLED'S) CHRM1, OCIAD1, OPRD1 ACHE 2334/4885TDP1 2309/4885NPC1 659/4885
US-20070080342-A1 Method for producing tris-ortho-metallated complexes and use of such complexes in oleds OCIAD1, OCIAD2, OXSR1 ACHE 1069/4885TDP1 1164/4885NPC1 1634/4885
US-20200266366-A1 TRANSITION METAL COMPLEXES COMPRISING CARBENE LIGANDS SERVING AS EMITTERS FOR ORGANIC LIGHT-EMITTING DIODES (OLED'S) CHRM1, OPRD1, DRD1 ACHE 2320/4885TDP1 3136/4885NPC1 1012/4885
US-20110049501-A1 TRANSITION METAL COMPLEXES COMPRISING CARBENE LIGANDS SERVING AS EMITTERS FOR ORGANIC LIGHT-EMITTING DIODES (OLED'S) CHRM1, OCIAD1, OPRD1 ACHE 2334/4885TDP1 2309/4885NPC1 659/4885
US-10573828-B2 Transition metal complexes comprising carbene ligands serving as emitters for organic light-emitting diodes (OLED's) OCIAD1, OPRD1, CHRM1 ACHE 2540/4885TDP1 2716/4885NPC1 809/4885
US-11539005-B2 Transition metal complexes comprising carbene ligands serving as emitters for organic light-emitting diodes (OLED's) CHRM1, OPRD1, DRD1 ACHE 2320/4885TDP1 3136/4885NPC1 1012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.